XML 135 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows      
Cash and cash equivalents $ 8,346 [1] $ 18,761 [1] $ 20,066
Restricted cash 8,772 [1] 27,979 [1] 28,324
Total cash and cash equivalents and restricted cash 17,118 46,740 48,390
Supplemental disclosure of cash flow information:      
Cash paid for interest 162,375 151,263 93,853
Supplemental disclosure of non-cash investing and financing activity:      
Debt obligations assumed (refer to Note 3)   99,995  
Issuance of common stock for acquisition of assets (refer to Note 3)   35,588  
Dividends declared to common shareholders 12,954 13,033 11,050
Non-cash interest accrued to debt balances 4,163 4,055 1,988
Accrued finance costs 691   $ 54
Accrued offering costs   $ 64  
Real estate transferred to real estate available and held for sale $ 3,366    
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities ("VIEs").